We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$172M
AUM Growth
Cap. Flow
+$174M
Cap. Flow %
101.18%
Top 10 Hldgs %
90.24%
Holding
33
New
32
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 86.63%
2 Energy 4.53%
3 Consumer Staples 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
26
Biogen
BIIB
$29.6B
$475K 0.28%
+1,400
New +$453K
PQUE
27
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
$456K 0.26%
+122,050
New +$456K
PXD
28
DELISTED
Pioneer Natural Resource Co.
PXD
$447K 0.26%
+3,000
New +$495K
PBYI icon
29
Puma Biotechnology
PBYI
$408M
$407K 0.24%
+2,150
New +$477K
AGIO icon
30
Agios Pharmaceuticals
AGIO
$2.16B
$381K 0.22%
+3,400
New +$304K
ROKA
31
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$379K 0.22%
+8,590
New +$544K
NXTM
32
DELISTED
NxStage Medical Inc.
NXTM
$264K 0.15%
+14,700
New +$237K
NSPR icon
33
InspireMD
NSPR
$32.5M
0

Similar funds

Birchview Capital's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Birchview Capital, which disclosed 33 positions worth $172M. Its ten largest holdings account for 90% of the portfolio.

Its largest position is Celgene Corp: 813,911 shares worth $91M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q4 2014 buy was Celgene Corp: 813,911 shares worth $91M.
  • Birchview Capital's ten largest holdings make up 90% of its $172M portfolio in Q4 2014.
  • Birchview Capital disclosed 33 positions in Q4 2014, its first 13F filing on record.

Based on Birchview Capital's 13F filing for Q4 2014, filed 6 Feb 2015.